Advertisement
Advertisement
U.S. markets open in 4 hours 7 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Qlife Holding AB (publ) (4HG.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
0.1524-0.0114 (-6.96%)
As of 09:08AM CET. Market open.
Advertisement

Qlife Holding AB (publ)

Redaregatan 48
Helsingborg 252 36
Sweden
45 21 63 35 34
https://www.qlifeholding.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees61

Key Executives

NameTitlePayExercisedYear Born
Mr. Thomas WarthoeCo-Founder, CEO & DirectorN/AN/A1967
Mr. Peter WarthoeCo-Founder & Chief Scientific OfficerN/AN/A1967
Mr. Kasper Damgaard Boel RousoeChief Financial OfficerN/AN/AN/A
Mr. Jakob Broberg LindGlobal Sales Director ClinicalN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Qlife Holding AB (publ), a med-tech company, manufactures and sells in-vitro diagnostic analyzers and reagents. The company offers Egoo.Health Platform, an integrated platform with a measuring instrument with disposable capsules and software, where each capsule contains a test for a specific biomarker or virus. Its biomarkers include C-reactive protein home-testing capsule, PHE/Phenylalanine for PKU patients, and Sars-CoV-2/Influenza multiplex for virus/bacteria tests. The company was incorporated in 2019 and is based in Helsingborg, Sweden.

Corporate Governance

Qlife Holding AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement